deferoxamine and rhodotorulic acid

deferoxamine has been researched along with rhodotorulic acid in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19908 (57.14)18.7374
1990's2 (14.29)18.2507
2000's2 (14.29)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdoukas, VA; Bhargava, KK; Cerami, A; Grady, RW; Graziano, JH; Jones, RL; Kokkini, G; Loukopoulos, D; Peterson, CM1
Graziano, JH1
Bulman, RA; Griffin, RJ; Russell, AT1
Baker, E; Grady, R; Page, M; Torrance, J1
Dailey, HA; Moody, MD1
Bhargava, KK; Cerami, A; Grady, RW; Peterson, CM1
Matzanke, BF; Müller, G; Raymond, KN1
Newsome, AL; Wilhelm, WE1
Davies, MJ; Evans, H; Green, ES; Rice-Evans, C; Rice-Evans, P; Salah, N1
Gendron, R; Grenier, D; Mayrand, D; Sorsa, T; Uitto, VJ1
Bauler, M; Klebba, PE; Moore, RE; Philpott, CC; Yun, CW1
Bockelmann, W; Bongers, RS; Noordman, WH; Rademaker, JL; Reissbrodt, R; Smit, G1
Funahashi, T; Mihara, K; Miyamoto, K; Tanabe, T; Tsujibo, H; Yamamoto, S1
Dubbin, WE; Goh, TB1

Reviews

2 review(s) available for deferoxamine and rhodotorulic acid

ArticleYear
Iron metabolism and chelation therapy in hemosiderosis.
    Current topics in hematology, 1978, Volume: 1

    Topics: Ascorbic Acid; Blood Transfusion; Chelating Agents; Deferoxamine; Diet; Gentisates; Hemochromatosis; Hemosiderosis; Hydroxamic Acids; Hydroxybenzoates; Iron; Piperazines; Syndrome

1978
Clinical management of thalassemia. The status of new iron chelators.
    Annals of the New York Academy of Sciences, 1980, Volume: 344

    Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cholic Acids; Deferoxamine; Drug Evaluation; Drug Evaluation, Preclinical; Enterobactin; Ethylenediamines; Humans; Hydroxamic Acids; Hydroxybenzoates; Iron; Pentetic Acid; Piperazines; Thalassemia

1980

Other Studies

12 other study(ies) available for deferoxamine and rhodotorulic acid

ArticleYear
Rhodotorulic acid--investigation of its potential as an iron-chelating drug.
    The Journal of pharmacology and experimental therapeutics, 1979, Volume: 209, Issue:3

    Topics: Adult; Animals; Deferoxamine; Dogs; Female; Haplorhini; Humans; Hydroxamic Acids; Hydroxybenzoates; Infusions, Parenteral; Injections, Intramuscular; Iron; Iron Chelating Agents; Macaca fascicularis; Male; Mice; Piperazines; Rats; Rhodotorula; Thalassemia

1979
An examination of some complexing agents for ability to remove intracellularly deposited plutonium.
    Health physics, 1979, Volume: 37, Issue:6

    Topics: Animals; Bone and Bones; Bufexamac; Chelating Agents; Chromones; Cricetinae; Deferoxamine; Female; Glycine; Hydroxamic Acids; Liver; Mesocricetus; Pentetic Acid; Piperazines; Plutonium; Pyridines

1979
Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Clinical physiology and biochemistry, 1985, Volume: 3, Issue:6

    Topics: Animals; Cell Membrane; Cells, Cultured; Chelating Agents; Cholic Acids; Deferoxamine; Ferritins; Iron; Kinetics; Liver; Piperazines; Rats; Transferrin

1985
Siderophore utilization and iron uptake by Rhodopseudomonas sphaeroides.
    Archives of biochemistry and biophysics, 1984, Volume: 234, Issue:1

    Topics: Biological Transport; Citrates; Culture Media; Deferoxamine; Iron; Iron Chelating Agents; Kinetics; Oxazoles; Photosynthesis; Piperazines; Rhodobacter sphaeroides; Siderophores

1984
Iron transport in Streptomyces pilosus mediated by ferrichrome siderophores, rhodotorulic acid, and enantio-rhodotorulic acid.
    Journal of bacteriology, 1984, Volume: 160, Issue:1

    Topics: Deferoxamine; Ferric Compounds; Iron; Iron Chelating Agents; Iron Radioisotopes; Kinetics; Piperazines; Streptomyces

1984
Inhibition of Naegleria fowleri by microbial iron-chelating agents: ecological implications.
    Applied and environmental microbiology, 1983, Volume: 45, Issue:2

    Topics: Amoeba; Animals; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Ecology; Iron; Piperazines; Water

1983
The efficacy of monohydroxamates as free radical scavenging agents compared with di- and trihydroxamates.
    Biochemical pharmacology, 1993, Jan-26, Volume: 45, Issue:2

    Topics: Deferoxamine; Deoxyribose; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Free Radical Scavengers; Humans; Hydroxamic Acids; Hydroxylamines; Lipid Peroxidation; Membrane Lipids; Piperazines; Spectrophotometry

1993
Effect of microbial siderophores on matrix metalloproteinase-2 activity.
    Journal of periodontal research, 1999, Volume: 34, Issue:1

    Topics: Bacteria; Calcium Chloride; Chelating Agents; Chlorides; Chromium; Collagen; Connective Tissue; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Extracellular Matrix; Ferric Compounds; Ferrichrome; Gelatinases; Humans; Hydroxybenzoates; Indicators and Reagents; Iron Chelating Agents; Macromolecular Substances; Matrix Metalloproteinase 2; Metalloendopeptidases; Periodontitis; Phenylmercuric Acetate; Phenylpyruvic Acids; Piperazines; Rosaniline Dyes; Siderophores; Sodium Dodecyl Sulfate; Sulfhydryl Reagents

1999
The role of the FRE family of plasma membrane reductases in the uptake of siderophore-iron in Saccharomyces cerevisiae.
    The Journal of biological chemistry, 2001, Mar-30, Volume: 276, Issue:13

    Topics: Carrier Proteins; Cell Membrane; Deferoxamine; Dose-Response Relationship, Drug; Enterobactin; Ferric Compounds; Ferrichrome; Fluorescent Antibody Technique, Indirect; FMN Reductase; Fungal Proteins; Iron; Membrane Transport Proteins; Microscopy, Fluorescence; NADH, NADPH Oxidoreductases; Oxidoreductases; Piperazines; Plasmids; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Siderophores; Transcription Factors

2001
Growth stimulation of Brevibacterium sp. by siderophores.
    Journal of applied microbiology, 2006, Volume: 101, Issue:3

    Topics: Bacteriological Techniques; Brevibacterium; Catechols; Culture Media; Deferoxamine; DNA, Bacterial; DNA, Ribosomal; Ethylenediamines; Ferric Compounds; Ferrichrome; Food Microbiology; Hydroxybenzoates; Iron; Iron Chelating Agents; Phylogeny; Piperazines; Siderophores

2006
Identification and characterization of an outer membrane receptor gene in Acinetobacter baumannii required for utilization of desferricoprogen, rhodotorulic acid, and desferrioxamine B as xenosiderophores.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:5

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Bacterial Outer Membrane Proteins; Base Sequence; Cloning, Molecular; Deferoxamine; Diketopiperazines; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Hydroxamic Acids; Imidazoles; Iron; Molecular Sequence Data; Oxazoles; Piperazines; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology; Siderophores; Transcription, Genetic

2012
Increased Solubility and Bioavailability of Hydroxy-Cr(III) Precipitates in the Presence of Hydroxamate Siderophores.
    Bulletin of environmental contamination and toxicology, 2018, Volume: 100, Issue:3

    Topics: Bentonite; Biological Availability; Chromium; Coordination Complexes; Deferoxamine; Piperazines; Soil Pollutants; Solubility; Surface Properties

2018